World News: 11:21 GMT Thursday 6th December 2018. [Research and Markets via Globe Newswire via SPi World News]
Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The report has been added to offering. The Global Urinary Incontinence Therapeutics Market is projected to grow at a CAGR of 3.12% during the period 2019-2023.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend affecting this market is the shift toward novel formulations. Many novel formulations are being developed for the treatment of urinary incontinence and they include the transdermal therapies and mechanism-of-action (MoA)-based therapies such as bete-3- adrenergic agonists and M3 specific anticholinergics.According to the report, one driver influencing this market is the robust pipeline for the development of drugs for urinary incontinence treatment. Most of the urinary incontinence therapeutics that are currently in Phase III stage are likely to get approved during the forecast period to augment the growth of the global urinary incontinence market. Furthermore, the increasing number of molecules being developed for urinary incontinence treatment will drive the demand for urinary incontinence therapeutics across the period of forecast.Further, the report states that one challenge affecting this market is the patent expiries of drugs. Since generic drugs are copies of branded drugs, they can be independently developed only after the expiry of patents of the original products which may impede the growth of the market.
For more information about this report visit
Research and Markets also offers services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Urological Disorders Drugs
Globe Newswire: 11:21 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.